Nature Machine Intelligence published guidelines for evaluating methods that use protein structure to predict binding to ligands. The article discusses deep-learning-based scoring functions used to generate poses and predict binding affinity in computational drug design.
The authors note the difficulties of comparing such scoring functions across studies for a specific task. Key validation conditions include disclosure of training data, code, and procedures, as well as protection against data leakage, sampling bias, and errors in experimental design.
The practical impact of the guidelines is to make results more reproducible, reusable, and accessible for independent verification. The source is presented as a publisher metadata synopsis, so details of the guidance and its applicability to individual models require further study.
editorial commentary
Why it matters
Probable consequence — tightening requirements for disclosure of data, code, and procedures when comparing methods for computational drug design. The next verifiable signal will be the appearance of the full text with specific protocols, datasets, and evaluation criteria. Substantial uncertainty stems from the fact that only a metadata synopsis is currently available, so the completeness and practical enforceability of the recommendations cannot be judged.